Description: Nutralogix Laboratories, Inc. operates as a sports nutraceutical company. It offers Green Tea extracts, a natural antioxidant and anticarcinogenic; L-Tyrosine, an amino acid that improves alertness, mental focus, enhances mood, and assists in weight loss and appetite suppression; Olive Leaf extracts, an antibiotic and antioxidant, which improves functions of the immune system; Gugulipid, an ethyl acetate extract; Caffeine, a central nervous system stimulant; Selenium, a trace mineral that acts as an antioxidant defending and maintaining its immune system; Evodiamine, a bioactive alkaloid extract, which acts as a stimulant with thermogenic effects; and Octopamine HCL, a fat loss agent. The company also provides Vitamin B6, a water-soluble vitamin; Chocamine, a cocoa extract; Citrus Aurantium extract, a biogenic amine that is used to assist in fat loss; and Coleus Forskohlii extract used for fat burning capabilities and assisting with lowering blood pressure. In addition, it provides Chromium for weight/fat loss; GABA that calms and relaxes mind and body; decreases pain from chronic conditions; and improves brain function and mental clarity, and sleep. Further, the company offers Bacopa Monnieri Extract, a plant with antioxidant properties that improves memory, mental clarity, and protein synthesis; Green Tea extracts, a natural antioxidant and anticarcinogenic; Cassia Novae extract, a plant extract that inhibits fat from being absorbed into the bloodstream; L-Theanine, a free amino acid found in tea and a specific species of mushrooms; and Coleus Forskohlii extract. Nutralogix Laboratories, Inc. is based in Weston, Florida.
1792 Bell Tower Lane
Weston,
FL
33326
United States
Phone:
954-392-1332
Officers
| Name | Title |
|---|---|
| Mr. Arne Rotne II | Chief Exec. Officer and Pres |
| Mr. Richard Mazzoni | Chief Operating Officer and Director |
| Ms. Natalie Perez | VP of Marketing & Corp. Communications and Director |
Exchange: OTCCE
Country: US
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0 |
| Price-to-Sales TTM: | 0 |
| IPO Date: | 2019-05-16 |
| Fiscal Year End: | |
| Full Time Employees: | 0 |